Dr. Angus Robinson has been a Consultant Clinical Oncologist in Brighton and Sussex since 2006. His oncology training included four years in Oxford, two years working as an overseas oncologist with VSO in Kampala, Uganda and one year of specialist training in Edinburgh Cancer Centre. His medical degree prior to this was at Nottingham University.
Having done an early physician Senior House Officer job at the Oncology Centre in Barts Hospital, he was then inspired into a career in oncology and started his specialist registrar training working in a variety of cancer centres.
His specialist interests currently are prostate cancer, looking after all stages of this disease from monitoring and active surveillance, hormonal treatment and specialist radiotherapy treatments for localised disease including IMRT, IGRT external beam radiotherapy and high dose rate brachytherapy.
He also looks after all stages of advanced prostate cancer and has a specialist interest in castration resistant metastatic disease and the novel treatments that have been developed recently in the management of this. He is the principle investigator locally for a number of national and international trials looking at improving outcomes in advanced prostate cancer.
In addition to Prostate cancer, as a uro-oncology specialist he also cares for patients with bladder and renal cancer.
He has been the Clinical Lead for the local Cancer Research Network, which has grown from a local Sussex Research Network to now having become part of the wider Kent Surrey and Sussex Cancer network.
He is also the Clinical Lead for the Specialist Upper gastrointestinal multi-disciplinary meeting which runs a weekly county wide Sussex oesophagogastric specialist discussion recommending the most appropriate staging investigations, and surgical and non surgical treatment options for patients with oesophageal and gastric cancers.
He looks after those patients with upper gastrointestinal cancers from East Sussex (Eastbourne and Hastings catchment) including tumours of the pancreas, biliary system, oesophagus and stomach.
Particular interest in the management of prostate cancer from early stage surveillance, radiation treatments for localized disease, drug treatments and running portfolio of clinical trials of novel treatments for prostate cancer.